» Articles » PMID: 22477807

Penicillin Prophylaxis in Children with Sickle Cell Disease

Overview
Specialty Pediatrics
Date 2012 Apr 6
PMID 22477807
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Children who have sickle cell disease and are under the age of five years are at increased risk of life-threatening pneumococcal infection due to absent or non-functional spleens and a decreased immune response. To prevent pneumococcal infection, the American Academy of Pediatrics recommends the use of penicillin prophylaxis in children with sickle cell disease under the age of five and in older children who have had a previous severe pneumococcal infection or have functional/surgical asplenia. These recommendations are based on two landmark studies, the first evaluating the effectiveness of penicillin prophylaxis and the second evaluating the duration of prophylaxis. Although the mortality rate from infection has been reduced following penicillin prophylaxis, altered immunologic response and penicillin-resistant S. pneumoniae remain a concern. This paper will review the literature that supports the use of penicillin prophylaxis, potential problems associated with prolonged therapy and recommendations for prophylaxis.

Citing Articles

Clinical Insights into Sickle Cell Disease: A Comprehensive Multicenter Retrospective Analysis of Clinical Characteristics and Outcomes Across Different Age Groups.

Almarghalani D, Alotaibi R, Alzlami T, Alhumaidi O, Alharthi N, Alboqami F J Clin Med. 2024; 13(23).

PMID: 39685683 PMC: 11641892. DOI: 10.3390/jcm13237224.


Management of diabetes mellitus patients with sickle cell anemia: Challenges and therapeutic approaches.

Obeagu E, Obeagu G Medicine (Baltimore). 2024; 103(17):e37941.

PMID: 38669382 PMC: 11049766. DOI: 10.1097/MD.0000000000037941.


Partial Splenic Embolization in Paediatric Sickle Cell Disease Patients with Hypersplenism.

Bazeboso J, Mbuyi Mukendi D, Mbongo C, Mbombo W, Lelo Tshikwela M, Molua A Cardiovasc Intervent Radiol. 2024; 47(5):652-660.

PMID: 38578371 DOI: 10.1007/s00270-024-03701-4.


Guarding Health: A Comprehensive Review of Nosocomial Infections in Sickle Cell Anemia, a Multifaceted Approach to Prevention.

Batra N, Acharya S, Ahuja A, Saboo K Cureus. 2024; 16(1):e53224.

PMID: 38425631 PMC: 10902742. DOI: 10.7759/cureus.53224.


Caregivers' knowledge, attitude, and perception toward pneumococcal infection prophylaxis in pediatric sickle cell disease patients in Kumasi, Ghana.

Doe E, Nguah S, Mensah K, Buabeng K Health Sci Rep. 2023; 6(11):e1665.

PMID: 37920656 PMC: 10618434. DOI: 10.1002/hsr2.1665.


References
1.
Halasa N, Shankar S, Talbot T, Arbogast P, Mitchel E, Wang W . Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007; 44(11):1428-33. DOI: 10.1086/516781. View

2.
Buchanan G, Siegel J, Smith S, DePasse B . Oral penicillin prophylaxis in children with imparied splenic function: a study of compliance. Pediatrics. 1982; 70(6):926-30. View

3.
Pai V, Nahata M . Duration of penicillin prophylaxis in sickle cell anemia: issues and controversies. Pharmacotherapy. 2000; 20(1):110-7. DOI: 10.1592/phco.20.1.110.34660. View

4.
Berkovitch M, Papadouris D, Shaw D, Onuaha N, Dias C, Olivieri N . Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell disease. Br J Clin Pharmacol. 1998; 45(6):605-7. PMC: 1873646. DOI: 10.1046/j.1365-2125.1998.00730.x. View

5.
Anglin D, Siegel J, Pacini D, Smith S, Adams G, Buchanan G . Effect of penicillin prophylaxis on nasopharyngeal colonization with Streptococcus pneumoniae in children with sickle cell anemia. J Pediatr. 1984; 104(1):18-22. DOI: 10.1016/s0022-3476(84)80582-x. View